AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics

A vaccine created using artificial intelligence that could potentially provide broader protection against multiple coronaviruses and help prepare for future outbreaks has passed its first human clinical trial.

Researchers from the Universities of Cambridge and Southampton developed a "universal vaccine" designed to protect against multiple Sarbeco coronaviruses, which the university explained in a news release is "the large group of viruses that occur in nature including SARS-CoV-2, which...